SEARCH

SEARCH BY CITATION

References

  • 1
    Moher D, Hopewell S, Schulz KF et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c869.
  • 2
    Dancey JE, Dobbin KK, Groshen S et al. Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents. Clin Cancer Res 2010; 16: 17451755.
  • 3
    Mallett S, Timmer A, Sauerbrei W, Altman DG. Reporting the prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines. Brit J Cancer 2010; 102: 173180.